Lv2
150 积分 2021-09-01 加入
Development of a 18F-Labeled Bicyclic Peptide Targeting EphA2 for Molecular Imaging of PSMA-Negative Prostate Cancer
1天前
已完结
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models
1天前
已完结
Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice
1天前
已完结
68Ga labeled EphA2-targeted cyclic peptide: a novel positron imaging tracer for triple-negative breast cancer?
26天前
已完结
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
26天前
已完结
Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists
28天前
已完结
Dual-payload ADCs move into first oncology clinical trials
1个月前
已完结
Somatostatin receptor 2 signaling promotes growth and tumor survival in small‐cell lung cancer
3个月前
已完结
Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity
3个月前
已完结
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin
3个月前
已完结
皖公网安备34019202002308
